Literature DB >> 21730086

Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality.

M E Gaillard1, D Bottero, C E Castuma, L A Basile, D Hozbor.   

Abstract

Although Bordetella pertussis contains and transcribes loci encoding type III secretion system (TTSS) homologues, expression of TTSS-associated proteins has been reported only for non-laboratory-adapted Irish clinical isolates. Here we confirm such a result for clinical isolates obtained from patients treated in Argentinean hospitals. Moreover, we demonstrate that the expression of TTSS-associated proteins is independent both of the year in which the isolate was obtained and of the types of polymorphic alleles for other virulence factors but is dependent on environmental growth conditions. Interestingly, we observed that TTSS-associated protein expression is lost after successive in vitro passages but becomes operative again when bacteria come into contact with the host. This in vivo activation of TTSS expression was observed not only for clinical isolates previously adapted to the laboratory after successive in vitro passages but also for vaccine strains that did not express the system in vitro. The reversibility of TTSS expression, demonstrated by its switching off-on when the bacterium comes into contact with the host, appears to be an adaptive response of this pathogen.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730086      PMCID: PMC3165473          DOI: 10.1128/IAI.00136-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Port of entry--the type III secretion translocon.

Authors:  Daniela Büttner; Ulla Bonas
Journal:  Trends Microbiol       Date:  2002-04       Impact factor: 17.079

2.  Characterization of the type III secretion locus of Bordetella pertussis.

Authors:  A Fauconnier; A Veithen; P Gueirard; R Antoine; L Wacheul; C Locht; A Bollen; E Godfroid
Journal:  Int J Med Microbiol       Date:  2001-03       Impact factor: 3.473

3.  Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis.

Authors:  D Hot; R Antoine; G Renauld-Mongénie; V Caro; B Hennuy; E Levillain; L Huot; G Wittmann; D Poncet; F Jacob-Dubuisson; C Guyard; F Rimlinger; L Aujame; E Godfroid; N Guiso; M-J Quentin-Millet; Y Lemoine; C Locht
Journal:  Mol Genet Genomics       Date:  2003-05-24       Impact factor: 3.291

Review 4.  Salmonella interactions with host cells: type III secretion at work.

Authors:  J E Galán
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

5.  Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.

Authors:  M H Yuk; E T Harvill; P A Cotter; J F Miller
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

6.  Regulation of type III secretion in Bordetella.

Authors:  Seema Mattoo; Ming H Yuk; Lisa L Huang; Jeff F Miller
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

Review 7.  Tools for genetic engineering in the amino acid-producing bacterium Corynebacterium glutamicum.

Authors:  Oliver Kirchner; Andreas Tauch
Journal:  J Biotechnol       Date:  2003-09-04       Impact factor: 3.307

8.  Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis.

Authors:  Franz von Götz; Susanne Häussler; Doris Jordan; Senthil Selvan Saravanamuthu; Dirk Wehmhöner; André Strüssmann; Joerg Lauber; Ina Attree; Jan Buer; Burkhard Tümmler; Ivo Steinmetz
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

9.  Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.

Authors:  Hyun-Ja Han; Asaomi Kuwae; Akio Abe; Yoshichika Arakawa; Kazunari Kamachi
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  16 in total

Review 1.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

2.  Cyclic di-GMP Regulates the Type III Secretion System and Virulence in Bordetella bronchiseptica.

Authors:  María de la Paz Gutierrez; Ting Y Wong; Fredrick Heath Damron; Julieta Fernández; Federico Sisti
Journal:  Infect Immun       Date:  2022-05-25       Impact factor: 3.609

Review 3.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice.

Authors:  Rodrigo Villarino Romero; Ilona Bibova; Ondrej Cerny; Branislav Vecerek; Tomas Wald; Oldrich Benada; Jana Zavadilova; Radim Osicka; Peter Sebo
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

5.  Glutamate Limitation, BvgAS Activation, and (p)ppGpp Regulate the Expression of the Bordetella pertussis Type 3 Secretion System.

Authors:  Tomoko Hanawa; Kazunari Kamachi; Hideo Yonezawa; Toshiyuki Fukutomi; Hayato Kawakami; Shigeru Kamiya
Journal:  J Bacteriol       Date:  2015-11-02       Impact factor: 3.490

6.  Comparative transcriptional analysis of homologous pathogenic and non-pathogenic Lawsonia intracellularis isolates in infected porcine cells.

Authors:  Fabio A Vannucci; Douglas N Foster; Connie J Gebhart
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

7.  Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.

Authors:  Noelia Olivera; Celina E Castuma; Daniela Hozbor; María E Gaillard; Martín Rumbo; Ricardo M Gómez
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

8.  Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.

Authors:  H Bailon; N León-Janampa; C Padilla; D Hozbor
Journal:  BMC Infect Dis       Date:  2016-08-17       Impact factor: 3.090

9.  Transcriptional profiling of Bordetella pertussis reveals requirement of RNA chaperone Hfq for Type III secretion system functionality.

Authors:  Ilona Bibova; David Hot; Kristina Keidel; Fabian Amman; Stephanie Slupek; Ondrej Cerny; Roy Gross; Branislav Vecerek
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

10.  Comparison of the Whole Cell Proteome and Secretome of Epidemic Bordetella pertussis Strains From the 2008-2012 Australian Epidemic Under Sulfate-Modulating Conditions.

Authors:  Laurence Don Wai Luu; Sophie Octavia; Ling Zhong; Mark J Raftery; Vitali Sintchenko; Ruiting Lan
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.